The myelofibrosis drug landscape has become more crowded since Syntara decided to focus on the disease in 2020, but the ...

Streamtec is on track to achieve a record-breaking £6m turnover, bolstered by new client wins. The Arbroath-based ...

He was surprised to discover, for example, that a photo of the GSK headquarters building attracted more positive comments than a story about a community partnership. A recent example of content ...

While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

GlaxoSmithKline Pharmaceuticals Limited ... towards renovation of its corporate office into a modern workplace. In September 2020, the Company launched tetravalent influenza flu vaccine, Fluarix ...

‘Sometimes you see people literally shaking as they come in, they never thought they would be in this position. It can be ...

For Save the Children, partnering with the pharmaceutical company GSK made sense when it came to the organizations ... several executives of companies and national brands with local headquarters. The ...

The maiden Fortune India MNC 500 showcases India's largest multinationals, with a cumulative total income of ₹36.77 lakh cr and ₹2.25 lakh cr in profits.

Talking to journalists at the company’s global headquarters in Basel ... of ResearchKit in pharma (along with others such as GlaxoSmithKline), and LaPorte says the technology has already ...

Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025 Anticipate completing enrollment in the PROGRESS-AD Phase 2 clinical trial of ...